Katharina Blatt

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.

Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.

Journal: Blood advances
Published: February 24, 2020

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.

Journal: Allergy
Published: November 09, 2018

Identification of a leukemia-initiating stem cell in human mast cell leukemia.

Identification of a leukemia-initiating stem cell in human mast cell leukemia.

Journal: Leukemia
Published: September 25, 2018

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Journal: Scientific reports
Published: April 30, 2018

Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.

Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.

Journal: Neoplasia (New York, N.Y.)
Published: February 08, 2018

Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments.

Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments.

Journal: Allergy
Published: December 22, 2017

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.

Journal: Allergy
Published: October 24, 2017

Midostaurin: a magic bullet that blocks mast cell expansion and activation.

Midostaurin: a magic bullet that blocks mast cell expansion and activation.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2017

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

Journal: Haematologica
Published: September 01, 2017

Variability of PD-L1 expression in mastocytosis.

Variability of PD-L1 expression in mastocytosis.

Journal: Blood advances
Published: August 11, 2017

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

Journal: Leukemia
Published: June 20, 2017

BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.

BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.

Journal: Allergy
Published: March 18, 2017
Showing 1-12 of 51

Last Updated: 09/26/2026